Mabion

Integrated modeling of upstream and downstream bioprocessing to improve biologics production efficiency

Poster

Integrated Modeling of Upstream and Downstream Bioprocessing to Improve Biologics Production Efficiency

Biologics, Drug development, Mabion, Manufacturing

Co-Development Partnership Models in Biologics Programs

Co-Development Partnership Models in Biologics Programs

Biologics, Drug development, Mabion, Partnership

Analytical Lifecycle for Monoclonal Antibodies

From Research to Release: Mapping Mabion’s Full Analytical Lifecycle for Monoclonal Antibodies

Analytics, Mabion, Monoclonal antibody

The New Era of Biosimilar Development: Seizing the Opportunity Under EMA’s Streamlined Guidelines

Biosimilars, Clinical trials, Drug development, EMA, FDA, Mabion, Regulatory

CDMO analytical expertise

Does Your CDMO Have An Analytical Edge?

Analytics, Biosimilars, Mabion

Quality in cooperation with biopharmaceutical company CDMO

Quality as the Basis for CDMO Partnership Success

polish CDMO

The Benefits of Outsourcing Your Biomanufacturing to a Polish CDMO

evaluating a CDMO proposal and RFP process

Four Steps To Identifying The CDMO Proposal Worth Signing

Novavax and Mabion Partnership on COVID-19 Vaccine

A synergy of excellence: Novavax-Mabion partnership on vaccine during unprecedented times amid the COVID-19 pandemic

Mabion, Vaccines